Clinical Expertise

The faculty has extensive experience in the use of intravesical BCG, Interferon, and Mitomycin in the management of superficial disease. There is a large experience with performance of radical cystectomy and all forms of continent diversion (orthotopic neobladder, cutaneous reservoir) for both men and women in the treatment of invasive disease.

Clinical Research

• Chemoprevention Trials

-         Oral DFMO vs Placebo (enrollment complete)

-         Celebrex + BCG vs BCG: a COX-2 receptor blocker

• p53 Based MVAC Chemotherapy Following Cystectomy of Organ Confined Invasive Cancer
• New Chemotherapy Combinations for Advanced Disease: Gemcitabine, Taxanes

Basic Science Research

• Methylation Defects in Tumors
• COX-2 Receptor Profiles in Tumors
• CAR Profiles and Potential Role in Gene Therapy

For more information about the Department of Urology, contact:

Phone: 214-648-4765, FAX: 214-648-4789

Mailing Address: 5323 Harry Hines Blvd., J8.148, Dallas, TX 75390-9110